PLVAP and idiopathic pulmonary fibrosis: We conjugated an anti-fibrotic small molecule to an anti-PV1 (αPV1) antibody and observe substantial reduction in the development of lung fibrosis (compared to an isotype control antibody) in an idiopathic pulmonary fibrosis (IPF) mouse model.